Skip to content

Clinical trials

Phase 2 Retinitis Pigmentosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 2 Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20072
20101
20121
20141
20171
20201
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurotech Pharmaceuticals3
jCyte, Inc3
Laboratoires Thea2
Aldeyra Therapeutics, Inc.1
Columbia University1
Foundation Fighting Blindness1
Nanoscope Therapeutics Inc.1
Radtke, Norman D., M.D.1
Retina Foundation of the Southwest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa14
Retinal Diseases5
Eye Diseases4
Usher Syndromes3
Eye Diseases, Hereditary2
Vision Disorders2
Central Serous Chorioretinopathy1
Cone-Rod Dystrophies1
Eye Abnormalities1
Genetic Diseases, Inborn1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.